(Q41100567)

26 September 2017

title

Pseudomonas aeruginosa nosocomial pneumonia: impact of pneumonia classification (English)

1 reference

26 September 2017

0 references

Pseudomonas aeruginosa

Pseudomonas aeruginosa

1 reference

5

1 reference

26 September 2017

Esther Calbo

11

0 references

Richard G. Wunderink

Richard Wunderink

12

0 references

Massimo Antonelli

Massimo Antonelli

7

0 references

Tobias Welte

8

Tobias Welte

1 reference

26 September 2017

2

Marin H Kollef

1 reference

26 September 2017

Scott T Micek

1

1 reference

26 September 2017

Antoni Torres

3

1 reference

26 September 2017

Catherine Chen

4

1 reference

26 September 2017

Jean Chastre

6

1 reference

26 September 2017

Bernard Clair

9

1 reference

26 September 2017

Helmut Ostermann

10

1 reference

26 September 2017

Francesco Menichetti

13

1 reference

26 September 2017

Garrett Schramm

14

1 reference

26 September 2017

Vandana Menon

15

1 reference

26 September 2017

publication date

20 July 2015

1 reference

Infection Control and Hospital Epidemiology

26 September 2017

published in

1 reference

26 September 2017

volume

36

1 reference

26 September 2017

issue

10

1 reference

26 September 2017

page(s)

1190-1197

1 reference

High prevalence of multidrug-resistant nonfermenters in hospital-acquired pneumonia in Asia

26 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1017%2FICE.2015.167

Clinical outcomes of Pseudomonas aeruginosa pneumonia in intensive care unit patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FICE.2015.167

Risk factors for drug-resistant pathogens in community-acquired and healthcare-associated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FICE.2015.167

Pandrug-resistant Pseudomonas aeruginosa among hospitalised patients: clinical features, risk-factors and outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FICE.2015.167

Nosocomial Pneumonia in the Intensive Care Unit Acquired by Mechanically Ventilated versus Nonventilated Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FICE.2015.167

Predictors of mortality in patients with infections due to multi-drug resistant Gram negative bacteria: the study, the patient, the bug or the drug?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FICE.2015.167

Microbiology of ventilator-associated pneumonia compared with that of hospital-acquired pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FICE.2015.167

Clinical characteristics and treatment patterns among patients with ventilator-associated pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FICE.2015.167

Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FICE.2015.167

Rapid ertapenem susceptibility testing and Klebsiella pneumoniae carbapenemase phenotype detection in Klebsiella pneumoniae isolates by use of automated microscopy of immobilized live bacterial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FICE.2015.167

Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FICE.2015.167

Effectiveness of treatments for severe sepsis: a prospective, multicenter, observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FICE.2015.167

Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour: results from a guideline-based performance improvement program

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FICE.2015.167

Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FICE.2015.167

Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FICE.2015.167

Inadequate treatment of ventilator-associated and hospital-acquired pneumonia: risk factors and impact on outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FICE.2015.167

A comparison of microbiology and demographics among patients with healthcare-associated, hospital-acquired, and ventilator-associated pneumonia: a retrospective analysis of 1184 patients from a large, international study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FICE.2015.167

A new strategy for healthcare-associated pneumonia: a 2-year prospective multicenter cohort study using risk factors for multidrug-resistant pathogens to select initial empiric therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FICE.2015.167

Rethinking the concepts of community-acquired and health-care-associated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FICE.2015.167

Health care-associated pneumonia and community-acquired pneumonia: a single-center experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FICE.2015.167

Broad-spectrum antimicrobials and the treatment of serious bacterial infections: getting it right up front

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FICE.2015.167

Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FICE.2015.167

Health care-associated pneumonia (HCAP): empiric antibiotics targeting methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa predict optimal outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FICE.2015.167

Optimal management therapy for Pseudomonas aeruginosa ventilator-associated pneumonia: An observational, multicenter study comparing monotherapy with combination antibiotic therapy*

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FICE.2015.167

A randomized trial of 7-day doripenem versus 10-day imipenem-cilastatin for ventilator-associated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FICE.2015.167

Ventilator-associated pneumonia due to Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FICE.2015.167

The epidemiology, pathogenesis and treatment of Pseudomonas aeruginosa infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FICE.2015.167

Validation of a clinical score for assessing the risk of resistant pathogens in patients with pneumonia presenting to the emergency department

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FICE.2015.167

Antimicrobial therapy escalation and hospital mortality among patients with health-care-associated pneumonia: a single-center experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FICE.2015.167

7 January 2021

Multicenter study of hospital-acquired pneumonia in non-ICU patients

1 reference

https://api.crossref.org/works/10.1017%2FICE.2015.167

7 January 2021

Ventilator-associated pneumonia caused by multidrug-resistant organisms or Pseudomonas aeruginosa: prevalence, incidence, risk factors, and outcomes

1 reference

https://api.crossref.org/works/10.1017%2FICE.2015.167

7 January 2021

Epidemiology, antibiotic therapy and clinical outcomes of healthcare-associated pneumonia in critically ill patients: a Spanish cohort study

1 reference

https://api.crossref.org/works/10.1017%2FICE.2015.167

7 January 2021

Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock

1 reference

https://api.crossref.org/works/10.1017%2FICE.2015.167

7 January 2021

Community-acquired pneumonia due to gram-negative bacteria and pseudomonas aeruginosa: incidence, risk, and prognosis

1 reference

https://api.crossref.org/works/10.1017%2FICE.2015.167

7 January 2021

Identifiers

DOI

10.1017/ICE.2015.167

1 reference

26 September 2017

1 reference